Hans Edgar Bishop, CEO & President at Juno Therapeutics, Inc. (JUNO), sold 161,342 shares at $30.30 ($4.9M) on 2016-09-21, disclosed to the SEC on 2016-09-21.
Open-market sale of $4.9M JUNO by CEO & President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.00 | 428 | $13K | 0.3% |
| 2 | $30.00 | 6,300 | $189K | 3.9% |
| 3 | $30.30 | 77,307 | $2.3M | 47.9% |
| 4 | $30.30 | 77,307 | $2.3M | 47.9% |
| Total | $30.29 avg | 161,342 | $4.9M | 100% |
| Filing → |
| JUNO | SELL | 2016-09-09 | $1.4M | — | Filing → |
| JUNO | SELL | 2016-09-02 | $2.6M | — | Filing → |
| JUNO | SELL | 2016-09-02 | $8.9M | — | Filing → |